Trial record 1 of 1 for:    NCT00136019
Previous Study | Return to List | Next Study

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

This study has been completed.
Information provided by:
UCB Pharma Identifier:
First received: August 24, 2005
Last updated: September 19, 2014
Last verified: July 2010